Dr. Jeremy Johnson has successfully defended his Ph.D. dissertation, "Examination of the Role of AMP-Activated Protein Kinase as a Therapeutic Modality for Triple Negative Breast Cancer." Congratulations to him, Dr. Mark Evers (mentor), committee members, and outside examiner. Also, thank you all who attended the seminar via Zoom during these unusual circumstances.
Jeremy Johnson.jpg